Biomaterials approaches to treating implant-associated osteomyelitis

Biomaterials

Volumn 81, Issue , 2016, Pages 58-71

  Inzana, Jason A ^a,b,c   Schwarz, Edward M ^b,c   Kates, Stephen L ^b   Awad, Hani A ^b,c  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c University of Rochester   (United States)

Author keywords

Antibiotics; Biomaterials; Drug delivery; Osteomyelitis; Staphylococcus aureus

Indexed keywords

ANIMALS; ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; BONE; BONE CEMENT; DRUG DELIVERY; ENZYME INHIBITION; ESTERS; IMPLANTS (SURGICAL); MICROORGANISMS; SURGERY;

ANTIBIOTIC RELEASE; BIODEGRA-DABLE MATERIALS; CLINICAL TRANSLATION; CLINICAL TREATMENTS; ORTHOPAEDIC DEVICES; OSTEOMYELITIS; POLY(METHYL METHACRYLATE) (PMMA); STAPHYLOCOCCUS AUREUS;

BIOMATERIALS;

ANTIBIOTIC AGENT; BIOMATERIAL; BONE CEMENT; POLY(METHYL METHACRYLATE); POLYMER; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BONE INFECTION; CERAMICS; CHRONIC OSTEOMYELITIS; COMPOSITE MATERIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; FOLLOW UP; HISTOPATHOLOGY; NONHUMAN; ORTHOPEDIC EQUIPMENT; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; HUMAN; MICROBIOLOGY; OSTEOMYELITIS; PROSTHESES AND ORTHOSES; STAPHYLOCOCCAL INFECTIONS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; HUMANS; OSTEOMYELITIS; PROSTHESES AND IMPLANTS; STAPHYLOCOCCAL INFECTIONS;

EID: 84953275272     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.12.012     Document Type: Review

References (151)

1. Abou Neel E.A., Bozec L., Knowles J.C., Syed O., Mudera V., Day R., Hyun J.K. Collagen-emerging collagen based therapies hit the patient. Adv. drug Deliv. Rev. 2013, 65:429-456.
2. Ahola N., Veiranto M., Mannisto N., Karp M., Rich J., Efimov A., Seppala J., Kellomaki M. Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis. Biomatter 2012, 2:213-225.
3. Alvarez H., Castro C., Moujir L., Perera A., Delgado A., Soriano I., Evora C., Sanchez E. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis. J. Biomed, Mater. Res. Part B Appl. Biomater. 2008, 85:93-104.
4. Amador G., Gautier H., Le Mabecque V., Miegeville A.F., Potel G., Bouler J.M., Weiss P., Caillon J., Jacqueline C. In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model. Antimicrob. Agents Chemother. 2010, 54:950-952.
5. Ambrose C.G., Clyburn T.A., Louden K., Joseph J., Wright J., Gulati P., Gogola G.R., Mikos A.G. Effective Treatment of Osteomyelitis with Biodegradable Microspheres in a Rabbit Model. Clin. Orthop. Relat. Res. 2004, 421:293-299.
6. Amin T.J., Lamping J.W., Hendricks K.J., McIff T.E. Increasing the elution of vancomycin from high-dose antibiotic-loaded bone cement: a novel preparation technique. J. Bone Jt. Surg. Am. 2012, 94:1946-1951.
7. Arciola C.R., Campoccia D., Gamberini S., Baldassarri L., Montanaro L. Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol. Lett. 2005, 246:81-86.
8. Basu S., Chryssikos T., Moghadam-Kia S., Zhuang H., Torigian D.A., Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin. Nucl. Med. 2009, 39:36-51.
9. Becker P.L., Smith R.A., Williams R.S., Dutkowsky J.P. Comparison of antibiotic release from polymethylmethacrylate beads and sponge collagen. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1994, 12:737-741.
10. Beeching N.J., Thomas M.G., Roberts S., Lang S.D. Comparative in-vitro activity of antibiotics incorporated in acrylic bone cement. J. Antimicrob. Chemother. 1986, 17:173-184.
11. Beenken K.E., Smith J.K., Skinner R.A., McLaren S.G., Bellamy W., Gruenwald M.J., Spencer H.J., Jennings J.A., Haggard W.O., Smeltzer M.S. Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis. J. Biomater. Appl. 2014, 29:514-523.
12. Bettin D., Winkler H. Comparative evaluation of results after local antibiotic therapy with gemtamycin in form of beads and fleece. J. Bone Jt. Surg. Br. 2009, 91-B:311.
13. Beuerlein M.J., McKee M.D. Calcium sulfates: what is the evidence?. J. Orthop. Trauma 2010, 24(Suppl. 1):S46-S51.
14. Bosse M.J., Gruber H.E., Ramp W.K. Internalization of bacteria by osteoblasts in a patient with recurrent, long-term osteomyelitis. A case report. J. Bone Jt. Surg. Am. 2005, 87:1343-1347.
15. Brin Y.S., Golenser J., Mizrahi B., Maoz G., Domb A.J., Peddada S., Tuvia S., Nyska A., Nyska M. Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J. Control. Release Off. J. Control. Release Soc. 2008, 131:121-127.
16. Brown K.V., Walker J.A., Cortez D.S., Murray C.K., Wenke J.C. Earlier debridement and antibiotic administration decrease infection. J. Surg. Orthop. Adv. 2010, 19:18-22.
17. Buchholz H.W., Engelbrecht H. Depot effects of various antibiotics mixed with palacos resins. Chirurg 1970, 41:511-515.
18. Calhoun J.H., Mader J.T. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin. Orthop. Relat. Res. 1997, (341):206-214.
19. Calhoun J.H., Manring M.M. Adult osteomyelitis. Infect. Dis. Clin. North Am. 2005, 19:765-786.
20. Calhoun J.H., Henry S.L., Anger D.M., Cobos J.A., Mader J.T. The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads. Clin. Orthop. Relat. Res. 1993, (295):23-27.
21. Cevher E., Orhan Z., Mulazimoglu L., Sensoy D., Alper M., Yildiz A., Ozsoy Y. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int. J. Pharm. 2006, 317:127-135.
22. Cevher E., Orhan Z., Sensoy D., Ahiskali R., Kan P.L., Sagirli O., Mulazimoglu L. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis. J. Microencapsul. 2007, 24:577-595.
23. Chen X., Tsukayama D.T., Kidder L.S., Bourgeault C.A., Schmidt A.H., Lew W.D. Characterization of a chronic infection in an internally-stabilized segmental defect in the rat femur. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 2005, 23:816-823.
24. Chen L., Wang H., Wang J., Chen M., Shang L. Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection. J. Biomed. Mater. Res. Part B Appl. Biomater. 2007, 83:589-595.
25. Ciampolini J., Harding K.G. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?. Postgrad. Med. J. 2000, 76:479-483.
26. Cornell C.N., Tyndall D., Waller S., Lane J.M., Brause B.D. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1993, 11:619-626.
27. Darouiche R.O., Mansouri M.D., Zakarevicz D., Alsharif A., Landon G.C. In vivo efficacy of antimicrobial-coated devices. J. Bone Jt. Surg. Am. 2007, 89:792-797.
28. Darouiche R.O. Treatment of infections associated with surgical implants. N. Engl. J. Med. 2004, 350:1422-1429.
29. Ding H., Zhao C.J., Cui X., Gu Y.F., Jia W.T., Rahaman M.N., Wang Y., Huang W.H., Zhang C.Q. A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis. PloS One 2014, 9:e85472.
30. Drago L., Boot W., Dimas K., Malizos K., Hansch G.M., Stuyck J., Gawlitta D., Romano C.L. Does implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro?. Clin. Orthop. Relat. Res. 2014, 472:3311-3323.
31. Duewelhenke N., Krut O., Eysel P. Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob. Agents Chemother. 2007, 51:54-63.
32. El-Kamel A.H., Baddour M.M. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation. Drug Deliv. 2007, 14:349-356.
33. Ethell M.T., Bennett R.A., Brown M.P., Merritt K., Davidson J.S., Tran T. In vitro elution of gentamicin, amikacin, and ceftiofur from polymethylmethacrylate and hydroxyapatite cement. Vet. Surg. 2000, 29:375-382.
34. Faber C., Stallmann H.P., Lyaruu D.M., Joosten U., von Eiff C., van Nieuw Amerongen A., Wuisman P.I. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model. Antimicrob. Agents Chemother. 2005, 49:2438-2444.
35. Ferguson J.Y., Dudareva M., Riley N.D., Stubbs D., Atkins B.L., McNally M.A. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Jt. J. 2014, 96-B:829-836.
36. Fitzpatrick F., Humphreys H., O'Gara J.P. The genetics of staphylococcal biofilm formation-will a greater understanding of pathogenesis lead to better management of device-related infection?. Clin. Microbiol. Infect. 2005, 11:967-973.
37. Fleiter N., Walter G., Bosebeck H., Vogt S., Buchner H., Hirschberger W., Hoffmann R. Clinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitis. Bone Jt. Res. 2014, 3:223-229.
38. Foster T.J., Geoghegan J.A., Ganesh V.K., Hook M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 2014, 12:49-62.
39. Francis K.P., Joh D., Bellinger-Kawahara C., Hawkinson M.J., Purchio T.F., Contag P.R. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 2000, 68:3594-3600.
40. Garcia L.G., Lemaire S., Kahl B.C., Becker K., Proctor R.A., Denis O., Tulkens P.M., Van Bambeke F. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J. Antimicrob. Chemother. 2013, 68:1455-1464.
41. Garvin K., Feschuk C. Polylactide-polyglycolide antibiotic implants. Clin. Orthop. Relat. Res. NA 2005, (437):105-110.
42. Garvin K.L., Miyano J.A., Robinson D., Giger D., Novak J., Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J. Bone Jt. Surg. Am. 1994, 76:1500-1506.
43. Giavaresi G., Bertazzoni Minelli E., Sartori M., Benini A., Della Bora T., Sambri V., Gaibani P., Borsari V., Salamanna F., Martini L., Nicoli Aldini N., Fini M. Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 2012, 30:348-355.
44. Giavaresi G., Bertazzoni Minelli E., Sartori M., Benini A., Parrilli A., Maltarello M.C., Salamanna F., Torricelli P., Giardino R., Fini M. New PMMA-based composites for preparing spacer devices in prosthetic infections. J. Mater. Sci. Mater. Med. 2012, 23:1247-1257.
45. Ginebra M.P., Traykova T., Planell J.A. Calcium phosphate cements as bone drug delivery systems: a review. J. Control. Release Off. J. Control. Release Soc. 2006, 113:102-110.
46. Gogia J.S., Meehan J.P., Di Cesare P.E., Jamali A.A. Local antibiotic therapy in osteomyelitis. Semin. Plastic Surg. 2009, 23:100-107.
47. Gristina A.G., Naylor P.T., Myrvik Q.N. Mechanisms of musculoskeletal sepsis. Orthop. Clin. N. Am. 1991, 22:363-371.
48. Gu Y., Chen X., Lee J.-H., Monteiro D.A., Wang H., Lee W.Y. Inkjet printed antibiotic- and calcium-eluting bioresorbable nanocomposite micropatterns for orthopedic implants. Acta Biomater. 2012, 8:424-431.
49. Guelcher S.A., Brown K.V., Li B., Guda T., Lee B.H., Wenke J.C. Dual-Purpose bone grafts improve healing and reduce infection. J. Orthop. Trauma 2011, 25:477-482.
50. Huntimer L., Ramer-Tait A.E., Petersen L.K., Ross K.A., Walz K.A., Wang C., Hostetter J., Narasimhan B., Wannemuehler M.J. Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery. Adv. Healthc. Mater. 2013, 2:369-378.
51. Inzana J.A., Olvera D., Fuller S.M., Kelly J.P., Graeve O.A., Schwarz E.M., Kates S.L., Awad H.A. 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials 2014, 35:4026-4034.
52. Inzana J.A., Schwarz E.M., Kates S.L., Awad H.A. A novel murine model of established Staphylococcal bone infection in the presence of a fracture fixation plate to study therapies utilizing antibiotic-laden spacers after revision surgery. Bone 2015, 72:128-136.
53. Inzana J.A., Trombetta R.P., Schwarz E.M., Kates S.L., Awad H.A. 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection. Eur. Cells Mater. 2015, 30:232-247.
54. Itokazu M., Yamamoto K., Yang W.Y., Aoki T., Kato N., Watanabe K. The sustained release of antibiotic from freeze-dried fibrin-antibiotic compound and efficacies in a rat model of osteomyelitis. Infection 1997, 25:359-363.
55. Itokazu M., Aoki T., Nonomura H., Nishimoto Y., Itoh Y. Antibiotic-loaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection. A preliminary report. Bull. Hosp. Jt. Dis. 1998, 57:125-129.
56. Jaeblon T. Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J. Am. Acad. Orthop. Surg. 2010, 18:297-305.
57. Jain J.P., Modi S., Domb A.J., Kumar N. Role of polyanhydrides as localized drug carriers. J. Control. Release Off. J. Control. Release Soc. 2005, 103:541-563.
58. Jain J.P., Modi S., Kumar N. Hydroxy fatty acid based polyanhydride as drug delivery system: synthesis, characterization, in vitro degradation, drug release, and biocompatibility. J. Biomed. Mater. Res. Part A 2008, 84:740-752.
59. Jia W.T., Zhang X., Luo S.H., Liu X., Huang W.H., Rahaman M.N., Day D.E., Zhang C.Q., Xie Z.P., Wang J.Q. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta Biomater. 2010, 6:812-819.
60. Jiang J.L., Li Y.F., Fang T.L., Zhou J., Li X.L., Wang Y.C., Dong J. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflamm. Res. 2012, 61:207-215.
61. Joosten U., Joist A., Frebel T., Brandt B., Diederichs S., von Eiff C. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials 2004, 25:4287-4295.
62. Joosten U., Joist A., Gosheger G., Liljenqvist U., Brandt B., von Eiff C. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials 2005, 26:5251-5258.
63. Keren I., Kaldalu N., Spoering A., Wang Y., Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 2004, 230:13-18.
64. Klemm K. Gentamicin-PMMA-beads in treating bone and soft tissue infections (author's transl). Zentralbl Chir. 1979, 104:934-942.
65. Knaepler H. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int. J. Surg. 2012, 10(Suppl. 1):S15-S20.
66. Koort J.K., Makinen T.J., Knuuti J., Jalava J., Aro H.T. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J. Nucl. Med. 2004, 45:1406-1411.
67. Koort J.K., Makinen T.J., Suokas E., Veiranto M., Jalava J., Knuuti J., Tormala P., Aro H.T. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 2005, 49:1502-1508.
68. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 1992, 33:1972-1980.
69. Kundu B., Nandi S.K., Dasgupta S., Datta S., Mukherjee P., Roy S., Singh A.K., Mandal T.K., Das P., Bhattacharya R., Basu D. Macro-to-micro porous special bioactive glass and ceftriaxone-sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial. J. Mater. Sci. Mater. Med. 2011, 22:705-720.
70. Kurien T., Pearson R.G., Scammell B.E. Bone graft substitutes currently available in orthopaedic practice: the evidence for their use. Bone Jt. J. 2013, 95-B:583-597.
71. Laurencin C.T., Gerhart T., Witschger P., Satcher R., Domb A., Rosenberg A.E., Hanff P., Edsberg L., Hayes W., Langer R. Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1993, 11:256-262.
72. Le Ray A.M., Gautier H., Laty M.K., Daculsi G., Merle C., Jacqueline C., Hamel A., Caillon J. In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(epsilon-caprolactone) microparticles. Antimicrob. Agents Chemother. 2005, 49:3025-3027.
73. Letsch R., Rosenthal E., Joka T. Local antibiotic administration in osteomyelitis treatment-a comparative study with two different carrier substances. Aktuelle Traumatol. 1993, 23:324-329.
74. Lew D.P., Waldvogel F.A. Osteomyelitis. Lancet 2004, 364:369-379.
75. Li B., Brown K.V., Wenke J.C., Guelcher S.A. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J. Control. Release Off. J. Control. Release Soc. 2010, 145:221-230.
76. Lora-Tamayo J., Murillo O., Iribarren J.A., Soriano A., Sanchez-Somolinos M., Baraia-Etxaburu J.M., Rico A., Palomino J., Rodriguez-Pardo D., Horcajada J.P., Benito N., Bahamonde A., Granados A., del Toro M.D., Cobo J., Riera M., Ramos A., Jover-Saenz A., Ariza J. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2013, 56:182-194. Infection RGftSoP.
77. Mader J.T., Stevens C.M., Stevens J.H., Ruble R., Lathrop J.T., Calhoun J.H. Treatment of experimental osteomyelitis with a fibrin sealant antibiotic implant. Clin. Orthop. Relat. Res. 2002, (403):58-72.
78. Makadia H.K., Siegel S.J. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polym. Basel. 2011, 3:1377-1397.
79. Mariconda M., Ascione T., Balato G., Rotondo R., Smeraglia F., Costa G.G., Conte M. Sonication of antibiotic-loaded cement spacers in a two-stage revision protocol for infected joint arthroplasty. BMC Musculoskelet. Disord. 2013, 14:193.
80. Masquelet A.C., Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop. Clin. N. Am. 2010, 41:27-37. table of contents.
81. McKee M.D., Li-Bland E.A., Wild L.M., Schemitsch E.H. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J. Orthop. Trauma 2010, 24:483-490.
82. McLaren A.C., Nelson C.L., McLaren S.G., De C.G.R. The effect of glycine filler on the elution rate of gentamicin from acrylic bone cement: a pilot study. Clin. Orthop. Relat. Res. 2004, (427):25-27.
83. McLaren A.C., McLaren S.G., Hickmon M.K. Sucrose, xylitol, and erythritol increase PMMA permeability for depot antibiotics. Clin. Orthop. Relat. Res. 2007, 461:60-63.
84. Mendel V., Simanowski H.J., Scholz H.C., Heymann H. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch. Orthop. Trauma Surg. 2005, 125:363-368.
85. Mihailescu R., Furustrand Tafin U., Corvec S., Oliva A., Betrisey B., Borens O., Trampuz A. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob. Agents Chemother. 2014, 58:2547-2553.
86. Molina-Manso D., Manzano M., Doadrio J.C., Del Prado G., Ortiz-Perez A., Vallet-Regi M., Gomez-Barrena E., Esteban J. Usefulness of SBA-15 mesoporous ceramics as a delivery system for vancomycin, rifampicin and linezolid: a preliminary report. Int. J. Antimicrob. Agents 2012, 40:252-256.
87. Moojen D.J., Hentenaar B., Charles Vogely H., Verbout A.J., Castelein R.M., Dhert W.J. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J. Arthroplasty 2008, 23:1152-1156.
88. Moreau J.L., Weir M.D., Xu H.H. Self-setting collagen-calcium phosphate bone cement: mechanical and cellular properties. J. Biomed. Mater. Res. Part A 2009, 91:605-613.
89. Murray C.K., Hsu J.R., Solomkin J.S., Keeling J.J., Andersen R.C., Ficke J.R., Calhoun J.H. Prevention and management of infections associated with combat-related extremity injuries. J. Trauma 2008, 64:S239-S251.
90. Nelson C.L., Evans R.P., Blaha J.D., Calhoun J., Henry S.L., Patzakis M.J. A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin. Orthop. Relat. Res. 1993, (295):96-101.
91. Nelson C.L., Hickmon S.G., Skinner R.A. Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride-gentamicin beads. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1997, 15:249-255.
92. Nishitani K., Sutipornpalangkul W., de Mesy Bentley K.L., Varrone J.J., Bello-Irizarry S.N., Ito H., Matsuda S., Kates S.L., Daiss J.L., Schwarz E.M. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 2015, 33:1311-1319.
93. Norden C.W., Myerowitz R.L., Keleti E. Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysis. Br. J. Exp. Pathol. 1980, 61:451-460.
94. Norden C.W. Experimental osteomyelitis. I. A description of the model. J. Infect. Dis. 1970, 122:410-418.
95. O'hara P., Hickey A.J. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm. Res. 2000, 17:955-961.
96. Orhan Z., Cevher E., Mulazimoglu L., Gurcan D., Alper M., Araman A., Ozsoy Y. The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model. J. Bone Jt. Surg. Br. 2006, 88:270-275.
97. Orhan Z., Cevher E., Yildiz A., Ahiskali R., Sensoy D., Mulazimoglu L. Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Archives Orthop. Trauma Surg. 2010, 130:135-142.
98. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu. Rev. Med. 2013, 64:175-188.
99. Overstreet D., McLaren A., Calara F., Vernon B., McLemore R. Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective. Clin. Orthop. Relat. Res. 2015, 473:337-347.
100. Patzakis M.J., Mazur K., Wilkins J., Sherman R., Holtom P. Septopal beads and autogenous bone grafting for bone defects in patients with chronic osteomyelitis. Clin. Orthop. Relat. Res. 1993, (295):112-118.
101. Pelissier P.H., Masquelet A.C., Bareille R., Pelissier S.M., Amedee J. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J. Orthop. Res. 2004, 22:73-79.
102. Penner M.J., Masri B.A., Duncan C.P. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J. Arthroplasty 1996, 11:939-944.
103. Perez R.A., Ginebra M.P. Injectable collagen/alpha-tricalcium phosphate cement: collagen-mineral phase interactions and cell response. J. Mater. Sci. Mater. Med. 2013, 24:381-393.
104. Perez R.A., Kim H.W., Ginebra M.P. Polymeric additives to enhance the functional properties of calcium phosphate cements. J. Tissue Eng. 2012, 3. 2041731412439555.
105. Raafat D., von Bargen K., Haas A., Sahl H.G. Insights into the mode of action of chitosan as an antibacterial compound. Appl. Environ. Microbiol. 2008, 74:3764-3773.
106. Rani S.A., Pitts B., Beyenal H., Veluchamy R.A., Lewandowski Z., Davison W.M., Buckingham-Meyer K., Stewart P.S. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J. Bacteriol. 2007, 189:4223-4233.
107. Rasyid H.N., van der Mei H.C., Frijlink H.W., Soegijoko S., van Horn J.R., Busscher H.J., Neut D. Concepts for increasing gentamicin release from handmade bone cement beads. Acta Orthop. 2009, 80:508-513.
108. Rathbone C.R., Cross J.D., Brown K.V., Murray C.K., Wenke J.C. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 2011, 29:1070-1074.
109. Reizner W., Hunter J.G., O'Malley N.T., Southgate R.D., Schwarz E.M., Kates S.L. A systematic review of animal models for Staphylococcus aureus osteomyelitis. Eur. Cells Mater. 2014, 27:196-212.
110. Rissing J.P., Buxton T.B., Fisher J., Harris R., Shockley R.K. Arachidonic acid facilitates experimental chronic osteomyelitis in rats. Infect. Immun. 1985, 49:141-144.
111. Romano C.L., Logoluso N., Meani E., Romano D., De Vecchi E., Vassena C., Drago L. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study. Bone Jt. J. 2014, 96-B:845-850.
112. Scheman L., Janota M., Lewin P. The production of experimental osteomyelitis: preliminary report. J. Am. Med. Assoc. 1941, 117:1525-1529.
113. Schmolders J., Hischebeth G.T., Friedrich M.J., Randau T.M., Wimmer M.D., Kohlhof H., Molitor E., Gravius S. Evidence of MRSE on a gentamicin and vancomycin impregnated polymethyl-methacrylate (PMMA) bone cement spacer after two-stage exchange arthroplasty due to periprosthetic joint infection of the knee. BMC Infect. Dis. 2014, 14:144.
114. Shaikh A.A., Ha C.W., Park Y.G., Park Y.B. Two-stage approach to primary TKA in infected arthritic knees using intraoperatively molded articulating cement spacers. Clin. Orthop. Relat. Res. 2014, 472:2201-2207.
115. Shanks R.M., Donegan N.P., Graber M.L., Buckingham S.E., Zegans M.E., Cheung A.L., O'Toole G.A. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 2005, 73:4596-4606.
116. Shi P., Zuo Y., Li X., Zou Q., Liu H., Zhang L., Li Y., Morsi Y.S. Gentamicin-impregnated chitosan/nanohydroxyapatite/ethyl cellulose microspheres granules for chronic osteomyelitis therapy. J. Biomed. Mater. Res. Part A 2010, 93:1020-1031.
117. Shirtliff M.E., Calhoun J.H., Mader J.T. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin. Orthop. Relat. Res. 2002, (401):239-247.
118. Sia I.G., Berbari E.F. Infection and musculoskeletal conditions: Osteomyelitis. Best. Pract. Res. Clin. Rheumatol. 2006, 20:1065-1081.
119. Smeltzer M.S., Thomas J.R., Hickmon S.G., Skinner R.A., Nelson C.L., Griffith D., Parr T.R., Evans R.P. Characterization of a rabbit model of staphylococcal osteomyelitis. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1997, 15:414-421.
120. Smith J.K., Moshref A.R., Jennings J.A., Courtney H.S., Haggard W.O. Chitosan sponges for local synergistic infection therapy: a pilot study. Clin. Orthop. Relat. Res. 2013, 471:3158-3164.
121. Solberg B.D., Gutow A.P., Baumgaertner M.R. Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J. Orthop. Trauma 1999, 13:102-106.
122. Spellberg B., Lipsky B.A. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2012, 54:393-407.
123. Stinner D.J., Noel S.P., Haggard W.O., Watson J.T., Wenke J.C. Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?. J. Orthop. Trauma 2010, 24:592-597.
124. Sugawara Y., Gutowski T.D., Fisher S.J., Brown R.S., Wahl R.L. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur. J. Nucl. Med. 1999, 26:333-341.
125. Takigami I., Ito Y., Ishimaru D., Ogawa H., Mori N., Shimizu T., Terabayashi N., Shimizu K. Two-stage revision surgery for hip prosthesis infection using antibiotic-loaded porous hydroxyapatite blocks. Arch. Orthop. Trauma Surg. 2010, 130:1221-1226.
126. Tamimi F., Kumarasami B., Doillon C., Gbureck U., Le Nihouannen D., Cabarcos E.L., Barralet J.E. Brushite-collagen composites for bone regeneration. Acta Biomater. 2008, 4:1315-1321.
127. Tan H., Ma R., Lin C., Liu Z., Tang T. Quaternized chitosan as an antimicrobial agent: antimicrobial activity, mechanism of action and biomedical applications in orthopedics. Int. J. Mol. Sci. 2013, 14:1854-1869.
128. Tang H.J., Chen C.C., Cheng K.C., Wu K.Y., Lin Y.C., Zhang C.C., Weng T.C., Yu W.L., Chiu Y.H., Toh H.S., Chiang S.R., Su B.A., Ko W.C., Chuang Y.C. In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2013, 57:5717-5720.
129. ter Boo G.J., Grijpma D.W., Moriarty T.F., Richards R.G., Eglin D. Antimicrobial delivery systems for local infection prophylaxis in orthopedic- and trauma surgery. Biomaterials 2015, 52:113-125.
130. Thein-Han W., Xu H.H. Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering. Tissue Eng. Part A 2011, 17:2943-2954.
131. Tofuku K., Koga H., Yanase M., Komiya S. The use of antibiotic-impregnated fibrin sealant for the prevention of surgical site infection associated with spinal instrumentation. Eur. Spine J. 2012, 21:2027-2033.
132. Trampuz A., Widmer A.F. Infections associated with orthopedic implants. Curr. Opin. Infect. Dis. 2006, 19:349-356.
133. Trampuz A., Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 2006, 37(Suppl. 2):S59-S66.
134. Tsiolis P., Giamarellos-Bourboulis E.J., Mavrogenis A.F., Savvidou O., Lallos S.N., Frangia K., Lazarettos I., Nikolaou V., Efstathopoulos N.E. Experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus treated with a polylactide carrier releasing linezolid. Surg. Infect. Larchmt. 2011, 12:131-135.
135. van de Belt H., Neut D., Schenk W., van Horn J.R., van der Mei H.C., Busscher H.J. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthop. Scand. 2000, 71:625-629.
136. Vergidis P., Rouse M.S., Euba G., Karau M.J., Schmidt S.M., Mandrekar J.N., Steckelberg J.M., Patel R. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis. Antimicrob. Agents Chemother. 2011, 55:1182-1186.
137. Wachol-Drewek Z., Pfeiffer M., Scholl E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 1996, 17:1733-1738.
138. Waeiss R.A., Negrini T.C., Arthur R.A., Bottino M.C. Antimicrobial effects of drug-containing electrospun matrices on osteomyelitis-associated pathogens. J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg. 2014, 72(7):1310-1319.
139. Walenkamp G.H., Kleijn L.L., de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop. Scand. 1998, 69:518-522.
140. Webb J.C., Spencer R.F. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery. J. Bone Jt. Surg. Br. 2007, 89:851-857.
141. Winkler H., Stoiber A., Kaudela K., Winter F., Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J. Bone Jt. Surg. Br. 2008, 90:1580-1584.
142. Xing J., Hou T., Luobu B., Luo F., Chen Q., Li Z., Jin H., Xu J. Anti-infection tissue engineering construct treating osteomyelitis in rabbit tibia. Tissue Eng. Part A 2013, 19:255-263.
143. Yagmurlu M.F., Korkusuz F., Gursel I., Korkusuz P., Ors U., Hasirci V. Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J. Biomed. Mater. Res. 1999, 46:494-503.
144. Yu B.G., Kwon I.C., Kim Y.H., Han D.K., Park K.D., Han K., Jeong S.Y. Development of a local antibiotic delivery system using fibrin glue. J. Control. Release 1996, 39:65-70.
145. Yun H.C., Branstetter J.G., Murray C.K. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J. Trauma 2008, 64:S163-S168. discussion S168.
146. Zelken J., Wanich T., Gardner M., Griffith M., Bostrom M. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis. Clin. Orthop. Relat. Res. 2007, 462:190-194.
147. Zhang X., Jia W., Gu Y., Xiao W., Liu X., Wang D., Zhang C., Huang W., Rahaman M.N., Day D.E., Zhou N. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials 2010, 31:5865-5874.
148. Zimmerli W., Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol. Med. Microbiol. 2012, 65(2):158-168.
149. Zimmerli W., Waldvogel F.A., Vaudaux P., Nydegger U.E. Pathogenesis of foreign body infection: description and characteristics of an animal model. J. Infect. Dis. 1982, 146:487-497.
150. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. N. Engl. J. Med. 2004, 351:1645-1654.
151. Zuluaga A.F., Galvis W., Jaimes F., Vesga O. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study. BMC Infect. Dis. 2002, 2:8.